D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$516M |
| 2 |
Estee Lauder
EL
|
+$487M |
| 3 |
Microsoft
MSFT
|
+$482M |
| 4 |
Nike
NKE
|
+$252M |
| 5 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$247M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$584M |
| 2 |
Tesla
TSLA
|
+$483M |
| 3 |
NVIDIA
NVDA
|
+$444M |
| 4 |
Eli Lilly
LLY
|
+$345M |
| 5 |
T-Mobile US
TMUS
|
+$296M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.67% |
| 2 | Consumer Discretionary | 9.3% |
| 3 | Healthcare | 7.82% |
| 4 | Financials | 5.66% |
| 5 | Industrials | 4.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3351
Healthcare Realty
HR
$7.42B
| $429K | ﹤0.01% |
28,120
-700
| -2% | -$12.4K |
|
3352
CALL
HP
HPQ
$23.5B
| $427K | ﹤0.01% |
16,600
-21,800
| -57% | -$669K |
|
3353
First American
FAF
$7.67B
| $424K | ﹤0.01% |
7,500
-13,300
| -64% | -$798K |
|
|
AHRT
3354
AH Realty Trust
AHRT
$534M
| $424K | ﹤0.01% |
+41,373
| New | +$480K |
|
3355
Cato Corp
CATO
$65.9M
| $422K | ﹤0.01% |
55,113
+3,558
| +7% | +$28.3K |
|
3356
BorgWarner
BWA
$13.2B
| $422K | ﹤0.01% |
10,442
-284
| -3% | -$12K |
|
3357
S&T Bancorp
STBA
$1.86B
| $420K | ﹤0.01% |
+15,517
| New | +$448K |
|
3358
Standard BioTools
LAB
$326M
| $419K | ﹤0.01% |
144,598
-199,099
| -58% | -$521K |
|
|
CETU
3359
DELISTED
Cetus Capital Acquisition Corp. Class A Common Stock
CETU
| $418K | ﹤0.01% |
40,000
| – | – |
|
3360
PureCycle Technologies
PCT
$1.17B
| $417K | ﹤0.01% |
+74,352
| New | +$697K |
|
3361
International Flavors & Fragrances
IFF
$19.4B
| $417K | ﹤0.01% |
6,112
-429,679
| -99% | -$31.4M |
|
3362
Herc Holdings
HRI
$5.43B
| $416K | ﹤0.01% |
3,500
+700
| +25% | +$91.3K |
|
|
FSP
3363
Franklin Street Properties
FSP
$44.8M
| $413K | ﹤0.01% |
223,490
-133,181
| -37% | -$236K |
|
|
MLNK
3364
DELISTED
MeridianLink
MLNK
| $413K | ﹤0.01% |
24,209
+5,643
| +30% | +$107K |
|
3365
Perrigo
PRGO
$1.4B
| $413K | ﹤0.01% |
+12,921
| New | +$455K |
|
3366
Zymeworks
ZYME
$1.68B
| $413K | ﹤0.01% |
65,068
+15,714
| +32% | +$116K |
|
3367
CALL
DuPont de Nemours
DD
$18.6B
| $410K | ﹤0.01% |
4,382
-28,122
| -87% | -$2.64M |
|
3368
Norwegian Cruise Line
NCLH
$8.89B
| $409K | ﹤0.01% |
24,819
-250,615
| -91% | -$4.62M |
|
3369
Arvinas
ARVN
$518M
| $409K | ﹤0.01% |
+20,800
| New | +$510K |
|
3370
Progyny
PGNY
$2.44B
| $408K | ﹤0.01% |
11,994
-113,991
| -90% | -$4.3M |
|
|
GRP.U
3371
DELISTED
Granite Real Estate Investment Trust
GRP.U
| $407K | ﹤0.01% |
7,668
-1,865
| -20% | -$106K |
|
|
CMPOW
3372
DELISTED
CompoSecure Inc Warrant
CMPOW
| $407K | ﹤0.01% |
616,569
| – | – |
|
3373
Utah Medical Products
UTMD
$214M
| $406K | ﹤0.01% |
4,716
+1,886
| +67% | +$174K |
|
3374
CALL
Advance Auto Parts
AAP
$3.37B
| $403K | ﹤0.01% |
+7,200
| New | +$482K |
|
|
MRNS
3375
CALL
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $403K | ﹤0.01% |
+50,000
| New | +$416K |
|
Similar funds
D.E. Shaw & Co's Q3 2023 Portfolio in Review
As of Q3 2023, D.E. Shaw & Co held 4,689 positions worth $95.8B, down 2.2% from $97.9B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co withdrew a net $2.99B in Q3 2023, closing 473 positions and reducing 1,535 holdings. Its most notable exit was State Street Consumer Staples Select Sector SPDR ETF, an estimated $174M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in NiSource Inc. Series A Corporate Units worth $52.6M.
- D.E. Shaw & Co's largest Q3 2023 buy was NiSource Inc. Series A Corporate Units: 540,000 shares worth $52.6M.
- D.E. Shaw & Co added most to Amazon in Q3 2023, an estimated $516M increase.
- D.E. Shaw & Co's biggest Q3 2023 reduction was Walmart Inc, cutting an estimated $584M.
- D.E. Shaw & Co fully exited State Street Consumer Staples Select Sector SPDR ETF in Q3 2023, selling an estimated $174M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $95.8B portfolio in Q3 2023.
- D.E. Shaw & Co opened 482 new positions and closed 473 in Q3 2023.
- D.E. Shaw & Co's portfolio value fell 2.2% quarter-over-quarter to $95.8B.
Based on D.E. Shaw & Co's 13F filing for Q3 2023, filed 14 Nov 2023.